AlphaYouJA
Insider selling
Jonathan Allan sold $44K of Stoke Therapeutics, Inc. (STOK) stock
Jonathan Allan, General Counsel & Corp Sec of Stoke Therapeutics, Inc. (STOK), sold 1,457 shares of STOK stock worth $44K, per an SEC Form 4 filed Jun 18, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jun 16, 2026, 2 days before it was made public.
STOK has moved -3.8% since the trade date, from $29.15 to $28.05 (Sep 21, 2026 close).
- Traded
- Jun 16, 2026
- Disclosed
- Jun 18, 2026
- Filing delay
- 2 days
- Price since
- -3.8%
- Role
- General Counsel & Corp Sec
- Source
- SEC Form 4
More STOK insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.